TradingView
RocketTickers
11. Okt. 2021 17:19

Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic process 

NYSE:MYOV1D

Beschreibung

⋅
MYOV: Enzyvant
2021-10-09 20:09:51
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia

Beyond Technical Analysis
Mehr